Browsing eNauka
Browsing by Author Kowalski, Dariusz
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2017 | Phase 3 safety evaluation of an intravenous formulation of NEPA, a novel fixed antiemetic combination of fosnetupitant and palonosetron | Schwartzberg, Lee Steven; Andric, Zoran G   ; Kowalski, Dariusz; Voisin, Daniel; Rizzi, Giada; Karthaus, Meinolf | Conference Paper | Mp. category will be shown later |
| 2017 | Phase 3 Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, with Docetaxel versus Docetaxel in Advanced Non-Small Cell Lung Cancer (GALAXY-2) | Pillai, Rathi N; Fennell, Dean; Kovcin, Vladimir N; Ciuleanu, Tudor E; Ramlau, Rodryg; Kowalski, Dariusz; Schenker, Michael; Perin, Branislav M; Yalcin, Ilker; Teofilovici, Florentina;
Vukovic, Vojo M; Ramalingam, Suresh S;
| Conference Paper | Mp. category will be shown later |
| 2017 | Phase III safety evaluation of intravenous NEPA, a novel fixed antiemetic combination of fosnetupitant and palonosetron, over multiple cycles | Schwartzberg, Lee Steven; Andric, Zoran G ; Kowalski, Dariusz; Voisin, Daniel; Rizzi, Giada; Karthaus, Meinolf | Conference Paper | Mp. category will be shown later |
| 2018 | Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy | Schwartzberg, Lee Steven; Roeland, E; Andric, Zoran G ; Kowalski, Dariusz; Radic, J; Voisin, Daniel; Rizzi, Giada; Navari, R; Gralla, Richard J; Karthaus, Meinolf | Article | 21a+M21a+ |
| 2020 | Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non?Small-Cell Lung Cancer (GALAXY-2) | Pillai, Rathi N; Fennell, Dean A; Kovcin, Vladimir N; Ciuleanu, Tudor E; Ramlau, Rodryg; Kowalski, Dariusz; Schenker, Michael; Yalcin, Ilker; Teofilovici, Florentina; Vukovic, Vojo M;
Ramalingam, Suresh S;
| Article | 21a+M21a+ |